This meta-analysis aims to determine whether non-steroidal anti-inflammatory drug (NSAID) use is significantly associated with adverse bone healing outcomes within clinical settings, including trauma and elective spine settings. It will also explore bone healing outcomes with the type, route, dosage and duration of NSAID exposure and aims to demonstrate the effects of various other confounding factors on bone healing outcomes.
Methods
Electronic databases including MedLine, Embase and Cochrane were searched from January 1975 to December 2017. A distinct analysis of observational long bone and spine studies in adult populations was performed, assessing the effects of NSAID exposure on bone healing. Studies from paediatric population and randomised trials also underwent separate assessment in the synthesis. Meta-analysis was conducted in compliance with QUORUM and PRISMA guidelines.
Results
Quantitative assessment of observational studies suggested a significant risk of bone healing complications with NSAID exposure across each clinical group: long bone (p = 0.0004) and spine (p = 0.02). Analysis of paediatric studies revealed a non-significant association of poor outcomes with NSAID use (p = 0.36), while assessment of randomised trials demonstrated a statistically significant risk of complications following NSAID administration (p = 0.04). Meta-regression further suggested smoking to be a substantial confounder associated with adverse bone healing outcomes (p < 0.00001).
Conclusion
Inclusion of only fair and moderate-quality retrospective cohort and case–control studies in the current synthesis limits the clinical application of its findings and therefore warrants the need for further research. Thus, attempts to conduct high-quality prospective cohort and randomised trials to study the effects of NSAID use on bone healing would be very helpful and will provide a basis for more extensive research in future.
KolarPSchmidt-BleekKSchellH, et al.The early fracture hematoma and its potential role in fracture healing. Tissue Eng Part B: Rev2010; 16: 427–434.
2.
ArikawaTOmuraKMoritaI. Regulation of bone morphogenetic protein-2 expression by endogenous prostaglandin E2 in human mesenchymal stem cells. J Cell Physiol2004; 200: 400–406.
3.
ParalkarVMGrasserWAMansolfAL, et al.Regulation of BMP-7 expression by retinoic acid and prostaglandin E2. J Cell Physiol2002; 190: 207–217.
4.
RaiszLG. Prostaglandins and bone: physiology and pathophysiology. Osteoarthritis Cartilage1999; 7: 419–421.
5.
VuolteenahoKMoilanenTMoilanenE. Non-steroidal anti-inflammatory drugs, cyclooxygenase-2 and the bone healing process. Basic Clin Pharmacol Toxicol2008; 102: 10–14.
6.
CaloriGMMazzaELMazzolaS, et al.Non-unions. Clin Cases Mineral Bone Metab2017; 14: 186–186.
7.
KanakarisNKGiannoudisPV. The health economics of the treatment of long-bone non-unions. Injury2007; 38: S77–S84.
8.
DodwellERLatorreJGParisiniE, et al.NSAID exposure and risk of nonunion: a meta-analysis of case-control and cohort studies. Calcif Tissue Int2010; 87: 193–202.
9.
SarmientoASharpeFEEbramzadehE, et al.Factors influencing the outcome of closed tibial fractures treated with functional bracing. Clin Orthopaed Relat Res1995; 315: 8–24.
10.
SchmitzMAFinneganMNatarajanR, et al.Effect of smoking on tibial shaft fracture healing. Clin Orthopaed Relat Res1999; 365: 184–200.
11.
OniOODunningJMobbsRJ, et al.Clinical factors and the size of the external callus in tibial shaft fractures. Clin Orthopaed Relat Res1991; 273: 278–283.
12.
Tytherleigh-StrongGMKeatingJF. Extra-articular fractures of the proximal tibial diaphysis: their epidemiology, management and outcome. J R Coll Surg Edinburgh1997; 42: 334–338.
13.
GastonPWillEEltonRA, et al.Fractures of the tibia: can their outcome be predicted?J Bone Jt Surg Br Vol1999; 81: 71–76.
14.
TemplemanDCGulliBTsukayamaDT, et al.Update on the management of open fractures of the tibial shaft. Clin Orthopaed Relat Res1998; 350: 18–25.
15.
FrymoyerJW. Fracture healing in rats treated with diphenylhydantoin (Dilantin). J Trauma1976; 16: 368–370.
16.
HuddlestonPMSteckelbergJMHanssenAD, et al.Ciprofloxacin inhibition of experimental fracture-healing. JBJS2000; 82: 161–173.
17.
DoddsRACatterallABitenskyL, et al.Effects on fracture healing of an antagonist of the vitamin K cycle. Calcif Tissue Int1984; 36: 233–238.
18.
StinchfieldFESankaranBSamilsonR. The effect of anticoagulant therapy on bone repair. JBJS1956; 38: 270–282.
19.
HogevoldHEGrogaardBReikerasO. Effects of short-term treatment with corticosteroids and indomethacin on bone healing: a mechanical study of osteotomies in rats. Acta Orthopaed Scand1992; 63: 607–611.
20.
CaloriGMAlbisettiWAgusA, et al.Risk factors contributing to fracture non-unions. Injury2007; 38: S11–S18.
21.
GastonMSSimpsonA. Inhibition of fracture healing. J Bone Jt Surg Br Vol2007; 89: 1553–1560.
22.
ChambersTJMcSheehyPMJThomsonBM, et al.The effect of calcium-regulating hormones and prostaglandins on bone resorption by osteoclasts disaggregated from neonatal rabbit bones. Endocrinology1985; 116: 234–239.
23.
NorrdinRWJeeWSSHighWB. The role of prostaglandins in bone in vivo. Prostagland Leukot Essent Fatty Acids1990; 41: 139–149.
24.
BennettASimpsonJMcDonaldA, et al.Breast cancer, prostaglandins, and bone metastases. Lancet1975; 305: 1218–1220.
25.
BlackwellKARaiszLGPilbeamCC. Prostaglandins in bone: bad cop, good cop?Trend Endocrinol Metab2010; 21: 294–301.
26.
BergmannPSchoutensA. Prostaglandins and bone. Bone1995; 16: 485–488.
27.
AkmanSGogusASenerN, et al.Effect of diclofenac sodium on union of tibial fractures in rats. Adv Ther2002; 19: 119–125.
28.
AltmanRDLattaLLKeerR, et al.Effect of nonsteroidal antiinflammatory drugs on fracture healing: a laboratory study in rats. J Orthopaed Trauma1994; 9: 392–400.
29.
EngesaeterLBSudmannBSudmannE. Fracture healing in rats inhibited by locally administered indomethacin. Acta Orthopaed Scand1992; 63: 330–333.
30.
GiannoudisPVMacDonaldDAMatthewsSJ, et al.Nonunion of the femoral diaphysis: the influence of reaming and non-steroidal anti-inflammatory drugs. Bone Jt J2000; 82: 655–658.
31.
SivaganesanAChotaiSWhite-DzuroG, et al.The effect of NSAIDs on spinal fusion: a cross-disciplinary review of biochemical, animal, and human studies. Eur Spine J2017; 26: 2719–2728.
32.
GerstenfeldLCThiedeMSeibertK, et al.Differential inhibition of fracture healing by non-selective and cyclooxygenas-2 selective non-steroidal anti-inflammatory drugs. J Orthopaed Res2003; 21: 670–675.
33.
Rainsford KD. Anti-inflammatory drugs in the 21st century. In: Harris RE (ed.) Inflammation in the pathogenesis of chronic diseases. Berlin: Springer, 2007, pp.3–27.
34.
OngCKSLirkPTanCH, et al.An evidence-based update on nonsteroidal anti-inflammatory drugs. Clin Med Res2007; 5: 19–34.
35.
Marquez-LaraAHutchinsonIDNunezFJr, et al.Nonsteroidal anti-inflammatory drugs and bone-healing: a systematic review of research quality. JBJS Rev2016; 4: e4–e4.
36.
AdolphsonPAbbaszadeganHJonssonU, et al.No effects of piroxicam on osteopenia and recovery after Colles' fracture. Arch Orthopaed Trauma Surg1993; 112: 127–130.
37.
BhattacharyyaTLevinRVrahasMS, et al.Nonsteroidal antiinflammatory drugs and nonunion of humeral shaft fractures. Arthrit Care Res2005; 53: 364–367.
38.
DavisTRAckroydCE. Non-steroidal anti-inflammatory agents in the management of Colles' fractures. Br J Clin Pract1988; 42: 184–189.
39.
PradhanBBTatsumiRLGallinaJ, et al.Ketorolac and spinal fusion: does the perioperative use of ketorolac really inhibit spinal fusion?Spine2008; 33: 2079–2082.
40.
BurdTAHughesMSAnglenJO. Heterotopic ossification prophylaxis with indomethacin increases the risk of long-bone nonunion. Bone Jt J2003; 85: 700–705.
41.
DeguchiMRapoffAJZdeblickTA. Posterolateral fusion for isthmic spondylolisthesis in adults: analysis of fusion rate and clinical results. J Spinal Disord1998; 11: 459–464.
42.
GlassmanSDRoseSMDimarJR, et al.The effect of postoperative nonsteroidal anti-inflammatory drug administration on spinal fusion. Spine1998; 23: 834–838.
43.
JeffcoachDRSamsVGLawsonCM, et al.Nonsteroidal anti-inflammatory drugs' impact on nonunion and infection rates in long-bone fractures. J Trauma Acute Care Surg2014; 76: 779–783.
44.
LumawigJMTYamazakiAWatanabeK. Dose-dependent inhibition of diclofenac sodium on posterior lumbar interbody fusion rates. Spine J2009; 9: 343–349.
45.
ParkS-YMoonS-HParkM-S, et al.The effects of ketorolac injected via patient controlled analgesia postoperatively on spinal fusion. Yonsei Med J2005; 46: 245–251.
46.
SagiHCJordanCJBareiDP, et al.Indomethacin prophylaxis for heterotopic ossification after acetabular fracture surgery increases the risk for nonunion of the posterior wall. J Orthopaed Trauma2014; 28: 377–383.
47.
JirarattanaphochaiKJungS. Nonsteroidal antiinflammatory drugs for postoperative pain management after lumbar spine surgery: a meta-analysis of randomized controlled trials. J Neurosurg Spine2008; 9: 22–31.
48.
MoherDLiberatiATetzlaffJ, et al.Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med2009; 151: 264–269.
49.
MoherDCookDJEastwoodS, et al.Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Oncol Res Treat2000; 23: 597–602.
50.
WellsGASheaBO'ConnellD, et al.The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses, Ottawa, ON: Ottawa Hospital Research Institute, 2000.
51.
FurlanADPennickVBombardierC, et al.Updated method guidelines for systematic reviews in the Cochrane Back Review Group. Spine2009; 34: 1929–1941.
52.
du PrelJ-BHommelGRohrigB, et al.Confidence interval or p-value?: Part 4 of a series on evaluation of scientific publications. Deutsches Arzteblatt Int2009; 106: 335–335.
53.
CrawfordCHCarreonLYDjurasovicM, et al.Lumbar fusion outcomes in patients with rheumatoid arthritis. Eur Spine J2008; 17: 822–825.
RitterMASieberJM. Prophylactic indomethacin for the prevention of heterotopic bone formation following total hip arthroplasty. Clin Orthopaed Relat Res1985; 196: 217–225.
56.
ReubenSSEkmanEF. The effect of cyclooxygenase-2 inhibition on analgesia and spinal fusion. JBJS2005; 87: 536–542.
57.
ReubenSS. Considerations in the use of Cox-2 inhibitors in spinal fusion surgery: in response. Anesthes Analg2001; 93: 803–804.
58.
ReubenSSAblettDKayeR. High dose nonsteroidal anti-inflammatory drugs compromise spinal fusion. Can J Anesth2005; 52: 506–512.
59.
DingLHeZXiaoH, et al.Factors affecting the incidence of aseptic nonunion after surgical fixation of humeral diaphyseal fracture. J Orthopaed Sci2014; 19: 973–977.
60.
DombroskiDGMacKenzieJManLX, et al.Postoperative aspirin use is associated with delayed progression of radiographic healing in tibial fractures treated with internal fixation. Univ Penn Orthop J2010; 20: 16–34.
61.
KayRMDirectoMPLeathersM, et al.Complications of ketorolac use in children undergoing operative fracture care. J Pediatr Orthopaed2010; 30: 655–658.
62.
BhandariMTornettaPSpragueS, et al.Predictors of reoperation following operative management of fractures of the tibial shaft. J Orthopaed Trauma2003; 17: 353–361.
63.
DePeterKCBlumbergSMBeckerSD, et al.Does the use of ibuprofen in children with extremity fractures increase their risk for bone healing complications?J Emerg Med2017; 52: 426–432.
64.
DonohueDSandersDSerrano-RieraR, et al.Ketorolac administered in the recovery room for acute pain management does not affect healing rates of femoral and tibial fractures. J Orthopaed Trauma2016; 30: 479–482.
65.
SucatoDJLovejoyJFAgrawalS, et al.Postoperative ketorolac does not predispose to pseudoarthrosis following posterior spinal fusion and instrumentation for adolescent idiopathic scoliosis. Spine2008; 33: 1119–1124.
66.
VitaleMGChoeJCHwangMW, et al.Use of ketorolac tromethamine in children undergoing scoliosis surgery: an analysis of complications. Spine J2003; 3: 55–62.
67.
HernandezRKDoTPCritchlowCW, et al.Patient-related risk factors for fracture-healing complications in the United Kingdom General Practice Research Database. Acta Orthopaed2012; 83: 653–660.
68.
BlomquistJSolheimELiavaagS, et al.Do nonsteroidal anti-inflammatory drugs affect the outcome of arthroscopic Bankart repair?Scand J Med Sci Sports2014; 24: e510–e514.
69.
BorrellB. A medical Madoff: anesthesiologist faked data in 21 studies. Scientific American,10 March 2009.
70.
MullerMENazarianSKochP. Classification AO des fractures: les os longs, Berlin: Springer-Verlag, 1987.
71.
ShrierIBoivinJ-FoSteeleRJ, et al.Should meta-analyses of interventions include observational studies in addition to randomized controlled trials? A critical examination of underlying principles. Am J Epidemiol2007; 166: 1203–1209.
72.
HigginsJPTGreenS. Cochrane handbook for systematic reviews of interventions, New Jersey: John Wiley & Sons, 2011.
73.
Court-BrownCMWillEChristieJ, et al.Reamed or unreamed nailing for closed tibial fractures: a prospective study in Tscherne C1 fractures. J Bone Jt Surg Br Vol1996; 78: 580–583.
74.
HabernekHWalchGDenggM, et al.Indications for surgical management of lower leg fractures. Unfallchirurgie1988; 14: 211–217.
75.
KempfIGrosseABeckG. Closed locked intramedullary nailing. Its application to comminuted fractures of the femur. JBJS1985; 67: 709–720.
76.
McKeeMDSeilerJGJupiterJB. The application of the limited contact dynamic compression plate in the upper extremity: an analysis of 114 consecutive cases. Injury1995; 26: 661–666.
77.
NicollEA. Fractures of the tibial shaft. J Bone Jt Surg Br Vol1964; 46: 373–387.
78.
SarmientoAHorowitchAAboulafiaA, et al.Functional bracing for comminuted extra-articular fractures of the distal third of the humerus. J Bone Jt Surg Br Vol1990; 72: 283–287.
79.
WinquistRASigvardHTJrClawsonDK. Closed intramedullary nailing of femoral fractures. A report of five hundred and twenty cases. Orthoped Trauma Direct2005; 3: 29–31.
80.
WissDABrienWWStetsonWB. Interlocked nailing for treatment of segmental fractures of the femur. J Bone Jt Surg Am Vol1990; 72: 724–728.
81.
WolinskyPRMcCartyEShyrY, et al.Reamed intramedullary nailing of the femur: 551 cases. J Trauma Acute Care Surg1999; 46: 392–399.
82.
ArnoldPMKlempJA. Assessment of malunion in spinal fusion. Neurosurg Q2005; 15: 239–247.
83.
LindamanLM. Bone healing in children. Clin Podiatr Med Surg2001; 18: 97–108.
84.
AdamsCIKeatingJFCourt-BrownCM. Cigarette smoking and open tibial fractures. Injury2001; 32: 61–65.
85.
CastilloRCBosseMJMacKenzieEJ, et al.Impact of smoking on fracture healing and risk of complications in limb-threatening open tibia fractures. J Orthopaed Trauma2005; 19: 151–157.
86.
ChahalJStephenDJGBulmerB, et al.Factors associated with outcome after subtalar arthrodesis. J Orthopaed Trauma2006; 20: 555–561.
87.
HilibrandASFyeMAEmerySE, et al.Impact of smoking on the outcome of anterior cervical arthrodesis with interbody or strut-grafting. JBJS2001; 83: 668–673.
88.
IshikawaSNMurphyGARichardsonEG. The effect of cigarette smoking on hindfoot fusions. Foot Ankle Int2002; 23: 996–998.
89.
McKeeMDDiPasqualeDJWildLM, et al.The effect of smoking on clinical outcome and complication rates following Ilizarov reconstruction. J Orthopaed Trauma2003; 17: 663–667.
